article thumbnail

SAEM Clinical Images Series: Insidiously Contracted Hand

ALiEM - Pharm Pearls

Risk factors for the development of Dupuytren’s contracture include northern European descent, age greater than 50 years, and diabetes. Repetitive motion occupations, tobacco use, alcohol use, and diabetes are key risk factors. Am Fam Physician 2007; 76:86. Case Question: What are the risk factors for this condition?

Diabetes 152
article thumbnail

Why the drug pricing debate is focused on insulin

pharmaphorum

It has now been 100 years since the first patient with diabetes received an injection of insulin, when Leonard Thomas, a 14-year-old boy, was treated with the hormone. In recent years, there have been more developments in the area of diabetes management, with the emergence of metformin and more recently semaglutide and dulaglutide.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sensyne launches fundraising, agrees patient data deal with Phesi

pharmaphorum

Oxford-based Sensyne uses patient data to improve drug development, disease understanding and clinical trial design, as well as to discover new drug targets, and also develops digital health software applications powered by AI such as GDm-Health for diabetes and CVm-Health for COVID-19. It already has access to around 6.1

article thumbnail

Insulin Injections

RX Note

Introduction In 2017, the Malaysian Diabetes Educators Society published the Forum for Injection Technique Malaysia (FIT-MY) to provide evidence-based injection technique recommendations for people with diabetes mellitus who use injectable therapy in their daily management. If you have not, repeat steps above.

article thumbnail

Why Balancing Blood Sugar is Vital for Hashimoto’s Health

The Thyroid Pharmacist

A review paper published in 2010 that discussed the relationship between thyroid dysfunction and metabolic disorders, highlighted the fact that patients with diabetes were up to three times more likely to develop a thyroid disorder. (7). Hypoglycemia is an early risk factor for developing diabetes. Type 2 Diabetes.

article thumbnail

FDA OKs first biosimilar of Roche’s blockbuster AMD drug Lucentis

pharmaphorum

The approval comes a few weeks after the biosimilar was cleared for marketing in the EU with a broader label, as it also includes diabetic macular oedema (DMO), another of Lucentis’ approved indications.

article thumbnail

Europe has its first Lucentis biosimilar, Samsung Bioepis’ Byooviz

pharmaphorum

Byooviz (ranibizumab, also known as SB11) has been cleared for the same indications as Lucentis – including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO – and will be sold in the EU by Biogen. Sales reached a peak in 2019, when Roche booked $1.8 billion in sales from the drug while Novartis made $2.1